Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000347079

Medchemexpress LLC Valproic acid | 99-66-1 | 99.7% | 144.21 | 250 MG
SDP

Catalog No. 5000347079
Encompass_Preferred

Valproic acid (VPA) is an orally active HDAC inhibitor. It inhibits HDAC1 and induces proteasomal degradation of HDAC2, while also activating Notch1 signaling and inhibiting proliferation in small cell lung cancer (SCLC) cells. This compound is utilized in various applications.

  • Orally active HDAC inhibitor
  • Inhibits HDAC1 and promotes proteasomal degradation of HDAC2
  • Activates Notch1 signaling
  • Inhibits proliferation in small cell lung cancer (SCLC) cells
  • Used in epilepsy
  • Used in bipolar disorder
  • Used in metabolic disease
  • Used in HIV infection
  • Used for the prevention of migraine headaches

Catalog No. 50-003-47079 Supplier Medchemexpress LLC Supplier No. 25GHY10585
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Valproic acid (VPA) is an orally active HDAC inhibitor. It inhibits HDAC1 and induces proteasomal degradation of HDAC2, while also activating Notch1 signaling and inhibiting proliferation in small cell lung cancer (SCLC) cells. This compound is utilized in various applications.

  • Orally active HDAC inhibitor
  • Inhibits HDAC1 and promotes proteasomal degradation of HDAC2
  • Activates Notch1 signaling
  • Inhibits proliferation in small cell lung cancer (SCLC) cells
  • Used in epilepsy
  • Used in bipolar disorder
  • Used in metabolic disease
  • Used in HIV infection
  • Used for the prevention of migraine headaches

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.